MabCure Company Description

MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer.

It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers.

The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan.

MabCure Inc. was founded in 2006 and is based in White Plains, New York.

MabCure, Inc.

Country	United States
Founded	2006
Industry	Solar
Sector	Technology
Employees	3
CEO	Jehu Thomas Hand

Contact Details

Address: 21 Sparrow Circle White Plains, New York 10605 United States
Phone	845 591 3144

Stock Details

Ticker Symbol	MBCI
Exchange	OTCMKTS
Fiscal Year	January - December
Reporting Currency	USD
ISIN Number	US5540941029
SIC Code	2836

Key Executives

Name	Position
Jehu Thomas Degerold Hand Esq.	Chief Executive and Financial Officer and Director